manganese dioxide has been researched along with Acute Confusional Senile Dementia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, S; Li, Y; Luo, H; Luo, Q; Yang, C | 1 |
| Abbasi, AZ; Ahmed, T; Bonin, RP; Foltz, WD; Fraser, PE; He, C; Henderson, JT; Li, LY; O'Flaherty, R; Park, E; Rauth, AM; Wu, XY; Zain, M | 1 |
| Dong, X; Gao, W; Liu, W; Sun, Y | 1 |
3 other study(ies) available for manganese dioxide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Nanozyme sensor array based on manganese dioxide for the distinction between multiple amyloid β peptides and their dynamic aggregation process.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Biosensing Techniques; Humans; Manganese Compounds; Oxides; Peptide Fragments | 2022 |
Brain-Penetrating and Disease Site-Targeting Manganese Dioxide-Polymer-Lipid Hybrid Nanoparticles Remodel Microenvironment of Alzheimer's Disease by Regulating Multiple Pathological Pathways.
Topics: Alzheimer Disease; Animals; Brain; Cell Hypoxia; Drug Delivery Systems; Lipids; Metal Nanoparticles; Mice; Oxidative Stress; Polymers | 2023 |
Albumin-manganese dioxide nanocomposites: a potent inhibitor and ROS scavenger against Alzheimer's β-amyloid fibrillogenesis and neuroinflammation.
Topics: Albumins; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Caenorhabditis elegans; Cell Line, Tumor; Humans; Manganese Compounds; Nanocomposites; Neuroblastoma; Neurodegenerative Diseases; Neuroinflammatory Diseases; Oxides; Reactive Oxygen Species | 2023 |